Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Apellis Pharmaceuticals, Inc. (APLS)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
10/10/2023
144/A
Form 144/A - Report of proposed sale of securities: [Amend]
10/10/2023
144
Form 144 - Report of proposed sale of securities:
10/05/2023
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
",
"
Apellis Announces Preliminary U.S. Net Revenues of Approximately $74 Million for SYFOVRE ® in the Third Quarter of 2023
"
08/22/2023
8-K
Other Events Interactive Data
08/08/2023
144
Form 144 - Report of proposed sale of securities:
07/31/2023
10-Q
Quarterly Report for the period ended June 30, 2023
07/31/2023
8-K
Quarterly results
07/18/2023
SC 13G
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/17/2023
8-K
Regulation FD Disclosure Interactive Data
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
"
07/17/2023
144
Form 144 - Report of proposed sale of securities:
07/10/2023
144
Form 144 - Report of proposed sale of securities:
07/07/2023
SC 13G/A
BlackRock Inc. reports a 4.9% stake in Apellis Pharmaceuticals Inc
07/03/2023
144
Form 144 - Report of proposed sale of securities:
07/03/2023
144
Form 144 - Report of proposed sale of securities:
06/08/2023
144
Form 144 - Report of proposed sale of securities:
06/01/2023
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
"
06/01/2023
144
Form 144 - Report of proposed sale of securities:
05/17/2023
144
Form 144 - Report of proposed sale of securities:
05/16/2023
144
Form 144 - Report of proposed sale of securities:
05/08/2023
144
Form 144 - Report of proposed sale of securities:
05/04/2023
10-Q
Quarterly Report for the period ended March 31, 2023
05/03/2023
144
Form 144 - Report of proposed sale of securities:
05/01/2023
144
Form 144 - Report of proposed sale of securities:
04/21/2023
ARS
Form ARS - Annual Report to Security Holders:
04/21/2023
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/21/2023
DEF 14A
Form DEF 14A - Other definitive proxy statements:
04/18/2023
144
Form 144 - Report of proposed sale of securities:
04/17/2023
144
Form 144 - Report of proposed sale of securities:
04/17/2023
144
Form 144 - Report of proposed sale of securities:
04/03/2023
144
Form 144 - Report of proposed sale of securities:
04/03/2023
144
Form 144 - Report of proposed sale of securities:
03/21/2023
144
Form 144 - Report of proposed sale of securities:
03/17/2023
144
Form 144 - Report of proposed sale of securities:
03/15/2023
8-K
Regulation FD Disclosure Interactive Data
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
"
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy